APRT
protein-codingadenine phosphoribosyltransferase
Gene summary
Adenine phosphoribosyltransferase belongs to the purine/pyrimidine phosphoribosyltransferase family. A conserved feature of this gene is the distribution of CpG dinucleotides. This enzyme catalyzes the formation of AMP and inorganic pyrophosphate from adenine and 5-phosphoribosyl-1-pyrophosphate (PRPP). It also produces adenine as a by-product of the polyamine biosynthesis pathway. A homozygous deficiency in this enzyme causes 2,8-dihydroxyadenine urolithiasis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~2.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013869
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013869
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0013869
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013869
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Musculoskeletal; Renal
Intervention: Biochemical; Renal
Rationale: Medical and dietary interventions (eg, purine-restricted diet with adequate hydration and allopurinol or febuxostat, in instances where allopurinol can not be used) may be beneficial in order to decrease the severity of manifestations including nephrolithiasis and renal sequelae, as well as to treat individuals with relatively advanced disease; Renal transplant has been described, and disease-specific considerations (eg, immediate postoperative pharmacotherapy) may impact transplant outcomes
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to APRT variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000485.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 20 | 22 | |||
| missense | 17 | 11 | 64 | 4 | 1 | 97 |
| nonsense | 6 | 5 | 11 | |||
| start loss | 4 | 4 | ||||
| frameshift | 13 | 6 | 19 | |||
| splice donor/acceptor (+/-2bp) | 4 | 4 | 1 | 9 | ||
| Total | 44 | 26 | 67 | 24 | 1 | 162 |
Highest pathogenic variant AF is 0.00018537026
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000476.1 | 5 | MANE Select | |
| Ensembl | ENSP00000367615.3 | 5 | MANE Select | |
| RefSeq | NP_001025189.1 | 5 | Standard | |
| Ensembl | ENSP00000397007.2 | 5 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Purine metabolism - Homo sapiens (human)
- Purine Nucleoside Phosphorylase Deficiency
- Mercaptopurine Action Pathway
- Azathioprine Action Pathway
- Xanthine Dehydrogenase Deficiency (Xanthinuria)
Biological Process
- purine ribonucleoside salvage
- adenine salvage
- lactation
- grooming behavior
- cellular response to insulin stimulus
Molecular Function
- adenine binding
- adenine phosphoribosyltransferase activity
- AMP binding
Cellular Component
- extracellular region
- nucleoplasm
- cytoplasm
- cytosol
- secretory granule lumen
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000378364
- Coding exons
- 5
- Length
- 2606
- Individuals with no LoFs
- 125581
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 33
- Defined
- 125614
- p
- 0.000131
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.238 | 110 | 103 | 1.07 | 0.00000563 | 1109 |
| Missense (PolyPhen) | 43 | 39.128 | 1.099 | 438 | ||
| Synonymous | -2.97 | 73 | 47.1 | 1.55 | 0.00000266 | 395 |
| Loss of Function | -2.03 | 15 | 8.57 | 1.75 | 5.06e-7 | 80 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.00017 | 0.00017 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00038 | 0.00038 | rare |
| Finnish | 0.000095 | 0.000092 | rare |
| European (Non-Finnish) | 0.00015 | 0.00014 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Catalyzes a salvage reaction resulting in the formation of AMP, that is energically less costly than de novo synthesis.;
- Disease
- DISEASE: Adenine phosphoribosyltransferase deficiency (APRTD) [MIM:614723]: An enzymatic deficiency that can lead to urolithiasis and renal failure. Patients have 2,8-dihydroxyadenine (DHA) urinary stones. {ECO:0000269|PubMed:11243733, ECO:0000269|PubMed:1353080, ECO:0000269|PubMed:15571218, ECO:0000269|PubMed:1746557, ECO:0000269|PubMed:21635362, ECO:0000269|PubMed:3343350, ECO:0000269|PubMed:3680503, ECO:0000269|PubMed:7915931}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0946
Intolerance Scores
- LoFtool
- 0.271
- RVIS EVS
- -0.1
- RVIS percentile EVS
- 46.49
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.988
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |